DREAMM13
A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 13 by
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
- Accepting patients
- Show Principal Investigator
Beverly Hills Cancer Center
Beverly Hills, CA
- Accepting patients
- Show Principal Investigator
University of Arizona Cancer Center
Tucson, AZ
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Aurora St. Luke's Medical Center
Milwaukee, WI
- Accepting patients
- Show Principal Investigator
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
- Accepting patients
- Show Principal Investigator
Cancer Center of Kansas (Heritage Plaza)
Wichita, KS
- Accepting patients
- Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Not yet accepting
- Show Principal Investigator
- Not yet accepting
- Show Principal Investigator
- Not yet accepting
- Show Principal Investigator
1,361 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.